Results 1 to 10 of about 24,454 (211)

Acromegaly Secondary to Ectopic Growth Hormone-Releasing Hormone Secretion From Metastatic Bronchial Carcinoid Tumor: A Case Report. [PDF]

Cureus
Anees SF, Abid IA.
europepmc   +1 more source

Postoperative Pituitary MRI Findings in Acromegaly: A Pictorial Review. [PDF]

Diagnostics (Basel)
Daskareh M, Abbasi F, Emamzadeh N, Shahmaei V, Ghorbani M.   +4 more
europepmc   +1 more source

Cardiomyopathy in women with acromegaly: clinical characteristics and associated factors in a Colombian multicenter registry. [PDF]

Front Endocrinol (Lausanne)
Sierra-Castillo S, Aristizabal-Colorado D, Arteaga-Arellano A, Miranda-Brazales D, Aquino Y, Muñoz-Ordoñez JA, Sierra-Castillo D, Peláez Ortiz JC, Vernaza Trujillo DA, Izquierdo-Condoy JS, Saldarriaga C, Abreu-Lomba A.   +11 more
europepmc   +1 more source

Micromegaly: a distinct clinical entity? Insights from a monocentric cohort study. [PDF]

Front Endocrinol (Lausanne)
Mangone A, Carosi G, Sala E, Marra G, Del Sindaco G, Mungari R, Cremaschi A, Lotito V, Peverelli E, Ferrante E, Mantovani G.   +10 more
europepmc   +1 more source

Proteomic profile of bone in patients with acromegaly: new insights from a pilot exploratory study. [PDF]

J Endocrinol Invest
Demarchis L, Chiloiro S, Mattogno PP, Cicchinelli M, Giambò P, Valeri F, Panizzi E, Angelini F, Giampietro A, Vodola E, Milardi D, D'Alessandris GQ, De Marinis L, Lauretti L, Rigante M, Bianchi A, Urbani A, Pontecorvi A, Doglietto F, Iavarone F.   +19 more
europepmc   +1 more source

MRI-based radiomics prediction of somatostatin receptor ligand response in acromegaly: an automated pipeline study. [PDF]

J Endocr Soc
Ruiz S, Mateu-Estivill R, Izquierdo-Gómez A, López-Máñez M, Alzate JA, Monté-Rubio G, de la Iglesia-Vayá M, Araujo-Castro M, Biagetti B, Sarria S, Vázquez F, Romero F, Valassi E, Navas V, Marazuela M, Puyalto P, Puig-Domingo M, ACROMICS/ACROFAST Research group, ACROMICS/ACROFAST Research group .   +18 more
europepmc   +1 more source

Beyond biochemical control: headache resolution with pasireotide in a patient with acromegaly and residual tumor. [PDF]

JCEM Case Rep
Ekhzaimy AA, Alghamdi A, Alghamlas S.
europepmc   +1 more source

Cost-effectiveness of pasireotide as second-line therapy for adult acromegaly patients from the perspective of the Brazilian Unified Health System. [PDF]

Front Endocrinol (Lausanne)
Dos Santos Nunes Nogueira V, Binowski G, Bronikowska M, Schmidt F, Gueron B, Paiva H, Kossi SD.   +6 more
europepmc   +1 more source